A retrospective analysis of the need for methylprednisolone in addition to IVIG for treating multisystem inflammatory syndrome in children.

Pal, Priyankar; Bathia, Jigna N; De, Hriday; Biswas, Debapoma; Bhelo, Mohini; Mondal, Anurag

Pal, Priyankar; Bathia, Jigna N; De, Hriday; Biswas, Debapoma; Bhelo, Mohini; Mondal, Anurag.

Afiliação

Pal P; Department of Pediatric Rheumatology.
Bathia JN; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
De H; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
Biswas D; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
Bhelo M; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
Mondal A; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

Rheumatology (Oxford) ; 61(6): e141-e142, 2022 05 30.

Article em En | MEDLINE | ID: mdl-35166768

Assuntos

COVID-19; Doenças do Tecido Conjuntivo; COVID-19/complicações; Criança; Humanos; Imunoglobulinas Intravenosas/uso terapêutico; Metilprednisolona/uso terapêutico; Estudos Retrospectivos; Síndrome de Resposta Inflamatória Sistêmica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Tecido Conjuntivo / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Rheumatology (Oxford) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google